Clinical Trial Update: Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS [Phase 4]

View source ↗

Summary

This Phase 4 trial update assesses the cost-effectiveness of adalimumab with surgery versus adalimumab alone in hidradenitis suppurativa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Hidradenitis Suppurativa | Phase 4 | Status: UNKNOWN